• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

原发性血小板增多症并发肺泡蛋白沉积症后发生骨髓纤维化。

Myelofibrosis after essential thrombocythemia complicated by alveolar proteinosis.

作者信息

Tsutsumi Yutaka, Tanaka Junji, Saito Shin, Tanaka Yasumasa, Kawamura Takahito, Obara Shinji, Noto Satosi, Shimoyama Norihiko, Asaka Masahiro, Imamura Masahiro, Masauzi Nobuo

机构信息

Department of Internal Medicine, Hakodate Municipal Hospital 1-10-1, Minato-Cho, Hakodate 041-8680, Japan.

出版信息

Leuk Lymphoma. 2003 Jun;44(6):1049-52. doi: 10.1080/1042819031000063453.

DOI:10.1080/1042819031000063453
PMID:12854908
Abstract

Hematological diseases are often accompanied by respiratory disorders. Pulmonary alveolar proteinosis (PAP) is a rare disease characterized by excessive accumulation of surfactant in the alveolar space. We describe a case of PAP complicated by myelofibrosis following essential thrombocythemia. The patient developed high fever, respiratory failure, and leuko-erythroblastosis during the progressive course of PAP. These symptoms were alleviated by prednisolone. The level of serum IL-6 was elevated when PAP was progressing rapidly. This may explain why the symptoms were alleviated by the steroids.

摘要

血液系统疾病常伴有呼吸系统疾病。肺泡蛋白沉积症(PAP)是一种罕见疾病,其特征是肺泡腔内表面活性物质过度积聚。我们描述了1例原发性血小板增多症后并发骨髓纤维化的PAP病例。在PAP的进展过程中,患者出现高热、呼吸衰竭和幼稚粒-幼红细胞血症。这些症状通过泼尼松龙得到缓解。当PAP迅速进展时,血清IL-6水平升高。这可能解释了为何使用类固醇可缓解症状。

相似文献

1
Myelofibrosis after essential thrombocythemia complicated by alveolar proteinosis.原发性血小板增多症并发肺泡蛋白沉积症后发生骨髓纤维化。
Leuk Lymphoma. 2003 Jun;44(6):1049-52. doi: 10.1080/1042819031000063453.
2
Elevated Serum Anti-GM-CSF Antibodies before the Onset of Autoimmune Pulmonary Alveolar Proteinosis in a Patient with Sarcoidosis and Systemic Sclerosis.结节病和系统性硬化症患者自身免疫性肺泡蛋白沉积症发病前血清抗GM-CSF抗体升高。
Tohoku J Exp Med. 2017 Sep;243(1):77-83. doi: 10.1620/tjem.243.77.
3
Lung cancer may develop subsequently or coincidently with pulmonary alveolar proteinosis.肺癌可能随后发生,或与肺泡蛋白沉积症同时发生。
Lung Cancer. 2007 Oct;58(1):144-8. doi: 10.1016/j.lungcan.2007.04.012. Epub 2007 Jun 13.
4
A case of uncomplicated pulmonary alveolar proteinosis evolving to pulmonary fibrosis.一例单纯型肺泡蛋白沉积症演变为肺纤维化的病例。
Monaldi Arch Chest Dis. 2007 Dec;67(4):234-7. doi: 10.4081/monaldi.2007.480.
5
Secondary Pulmonary Alveolar Proteinosis Associated with Primary Myelofibrosis and Ruxolitinib Treatment: An Autopsy Case.与原发性骨髓纤维化和芦可替尼治疗相关的继发性肺泡蛋白沉积症:一例尸检病例
Intern Med. 2020 Aug 15;59(16):2023-2028. doi: 10.2169/internalmedicine.4082-19. Epub 2020 May 23.
6
Relevance of bone marrow features in the differential diagnosis between essential thrombocythemia and early stage idiopathic myelofibrosis.骨髓特征在原发性血小板增多症与早期特发性骨髓纤维化鉴别诊断中的相关性
Haematologica. 2000 Nov;85(11):1126-34.
7
GM-CSF Autoantibody-positive Pulmonary Alveolar Proteinosis with Simultaneous Myeloproliferative Neoplasm.伴有同时性骨髓增殖性肿瘤的GM-CSF自身抗体阳性肺泡蛋白沉积症
Intern Med. 2017;56(4):435-439. doi: 10.2169/internalmedicine.56.6920. Epub 2017 Feb 15.
8
Pulmonary alveolar proteinosis and end-stage pulmonary fibrosis: a rare association.肺泡蛋白沉积症与终末期肺纤维化:一种罕见的关联。
J Thorac Imaging. 2005 Aug;20(3):242-4. doi: 10.1097/01.rti.0000160733.74997.2d.
9
Rare Presentation of Pulmonary Alveolar Proteinosis Causing Acute Respiratory Failure.肺泡蛋白沉积症导致急性呼吸衰竭的罕见表现。
Can Respir J. 2016;2016:4064539. doi: 10.1155/2016/4064539. Epub 2016 May 16.
10
[Transition from idiopathic sideroblastic anemia into acute myelofibrosis].
Orv Hetil. 1986 Aug 3;127(31):1865-70.

引用本文的文献

1
Unusual cause of dyspnea in patient with Myelofibrosis: The Ruxolitinib lung.骨髓纤维化患者呼吸困难的不寻常原因:鲁索替尼肺。
Respir Med Case Rep. 2024 Aug 5;51:102090. doi: 10.1016/j.rmcr.2024.102090. eCollection 2024.
2
Pathogenesis-driven treatment of primary pulmonary alveolar proteinosis.以发病机制为导向的原发性肺泡蛋白沉积症治疗。
Eur Respir Rev. 2024 Aug 14;33(173). doi: 10.1183/16000617.0064-2024. Print 2024 Jul.
3
Secondary Pulmonary Alveolar Proteinosis Associated with Primary Myelofibrosis and Ruxolitinib Treatment: An Autopsy Case.
与原发性骨髓纤维化和芦可替尼治疗相关的继发性肺泡蛋白沉积症:一例尸检病例
Intern Med. 2020 Aug 15;59(16):2023-2028. doi: 10.2169/internalmedicine.4082-19. Epub 2020 May 23.